Abbas Hussain - 02 Oct 2025 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role
Director
Signature
/s/ James Dillon, As Attorney-in-Fact
Issuer symbol
MRNA
Transactions as of
02 Oct 2025
Transactions value $
$0
Form type
4
Filing time
06 Oct 2025, 16:14:33 UTC
Previous filing
04 Aug 2025
Next filing
11 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hussain Abbas Director C/O MODERNA, INC., 325 BINNEY STREET, CAMBRIDGE /s/ James Dillon, As Attorney-in-Fact 06 Oct 2025 0001821956

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRNA Common Stock Options Exercise +1.44K +248.1% 2.02K 02 Oct 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRNA Restricted Stock Units Options Exercise $0 -1.44K -100% $0.00 0 02 Oct 2025 Common Stock 1.44K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 The shares subject to this restricted stock unit award vested in full on October 2, 2025.